Abstract
To examine in detail spinal nerve defects induced by prenatal exposure to valproic acid in mice, pregnant ICR mice were subcutaneously injected with a single dose of 400 mg/kg valproic acid on gestational day 6, 7, 8, or 9, and their embryos were observed on gestational day 10. The whole-mount immunostaining using an anti-neurofilament antibody allowed us to identify spinal nerve defects, such as a loss of bundle, anastomosis among bundles arising from adjacent segment, and a disrupted segmental pattern of the dorsal root ganglia, in valproic acid-exposed embryos. The prevalence of spinal nerve defects was the highest in the embryos exposed to valproic acid on gestational day 8 among the experimental groups. Then, effects of the administration dose of valproic acid on the prevalence of spinal nerve defects were examined on gestational day 10 and found to be dose-dependently increased. It was noteworthy that all embryos exposed to 600 mg/kg of valproic acid on gestational day 8 suffered spinal nerve defects. Folic acid (3 mg/kg/day) supplementation during gestational day 6–10 suppressed the prevalence of valproic acid-induced neural tube defects, which are common malformations in offspring prenatally exposed to valproic acid, but not that of spinal nerve defects. Thus, the spinal nerve defects due to prenatal valproic acid exposure might be induced by mechanisms different from those of neural tube defects. Because spinal nerve defects were predicted to be caused by the disrupted segmental arrangement of the somites and/or that of neural crest cells, which was the origin of the dorsal root ganglia and/or abnormal polarity of the somite, this mouse model with spinal nerve defects at high incidence would be useful to examine the effects of valproic acid on the somitogenesis and morphogenesis of somite-associated structures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baker RE, Schnell S, Maini PK (2006) A clock and wavefront mechanism for somite formation. Dev Biol 293:116–126
Bambini-Junior V, Rodrigues L, Behr GA, Moreira JC, Riesgo R, Gottfried C (2011) Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res 1408:8–16
Barnes GL Jr, Mariani BD, Tuan RS (1996) Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression. Teratology 54:93–102
Bromely RL, Mawer G, Clayton-Smith J, Baker GA (2008) Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 71:1923–1924
Christensen J, Grønborg TK, Sørensen MJ et al (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696–1703
Cooke K, Zeeman EC (1976) A clock and wavefront model for control of the number of repeated structures during animal morphogenesis. J Theor Biol 58:455–476
Dequéant ML, Pourquié O (2008) Segmental patterning of the vertebrate embryonic axis. Nat Rev Genet 9:370–382
Di Renzo F, Broccia ML, Giavini E, Menegola E (2010) VPA-related axial skeletal defects and apoptosis: a proposed event cascade. Reprod Toxicol 29:106–111
Evrard YA, Lun Y, Aulehla A, Gan L, Johnson RL (1998) Lunatic fringe is an essential mediator of somite segmentation and patterning. Nature 394:377–381
Fuller LC, Cornelius SK, Murphy CW, Wiens DJ (2002) Neural crest cell motility in valproic acid. Reprod Toxicol 16:825–839
Gilbert SF (2014) Developmental biology, 10th edn. Sinauer Associates, Sunderland
Gofflot F, van Maele-Fabry G, Picard JJ (1996) Cranial nerves and ganglia are altered after in vitro treatment of mouse embryos with valproic acid (VPA) and 4-en-VPA. Brain Res Dev Brain Res 93:62–69
Hubaud A, Pourquié O (2014) Signalling dynamics in vertebrate segmentation. Nat Rev Mol Cell Biol 15:709–721
Jentink J, Loane MA, Dolk H et al (2010) Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362:2185–2193
Kuan C-YK, Tannahill D, Cook GMW, Keynes RJ (2004) Somite polarity and segmental patterning of the peripheral nervous system. Mechan Dev 121:1055–1068
Lee YM, Osumi-Yamashita N, Ninomiya Y, Moon CK, Eriksson U, Eto K (1995) Retinoic acid stage-dependently alters the migration pattern and identity of hindbrain neural crest cells. Development 121:825–837
Luxey M, Jungas T, Laussu J, Audouard C, Garces A, Davy A (2013) Eph: ephrin-B1 forward signaling controls fasciculation of sensory and motor axons. Dev Biol 383:264–274
Meador KJ, Baker GA, Browning N et al (2013) Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years: a prospective observational study. Lancet Neurol 12:244–252
Menegola E, Broccia ML, Prati M, Giavini E (1999) Morphological alterations induced by sodium valproate on somites and spinal nerves in rat embryos. Teratology 59:110–119
Narita M, Oyabu A, Imura Y et al (2010) Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. Neurosci Res 66:2–6
Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M (2004) Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Birth Def Res 71:47–53
Ornoy A (2006) Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 22:214–226
Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28:1–10
Osumi N, Hirota A, Ohuchi H et al (1997) Pax-6 is involved in the specification of hindbrain motor neuron subtype. Development 124:2961–2972
Padmanabhan R, Hameed MS (1994) Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. J Craniofac Genet Dev Biol 14:192–205
Roffers-Agarwal J, Gammill LS (2009) Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation. Development 136:1879–1888
Roullet FI, Wollaston L, DeCatanzaro D, Foster JA (2010) Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 170:514–522
Sato Y, Yasuda K, Takahashi Y (2002) Morphological boundary forms by a novel inductive event mediated by Lunatic fringe and Notch during somatic segmentation. Development 129:3633–3644
Stockhausen MT, Sjölund J, Manetopoulos C, Axelson H (2005) Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br J Cancer 92:751–759
Sun G, Mackey LV, Coy DH, Yu CY, Sun L (2015) The histone deacetylase inhibitor valproic acid induces cell growth arrest in hepatocellular carcinoma cells via suppressing Notch signaling. J Cancer 6:996–1004
Vermeren MM, Cook GMW, Johnson AR, Keynes RJ, Tannahill D (2000) Spinal nerve segmentation in the chick embryo: analysis of distinct axon-repulsive systems. Dev Biol 225:241–252
Yabe T, Takeda S (2016) Molecular mechanism for cyclic generation of somites: lessons from mice and zebrafish. Develop Growth Differ 58:31–42
Acknowledgments
This work was supported by JSPS KAKENHI grant nos. 23591595 and 26461634.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest in this work.
Rights and permissions
About this article
Cite this article
Bold, J., Sakata-Haga, H. & Fukui, Y. Spinal nerve defects in mouse embryos prenatally exposed to valproic acid. Anat Sci Int 93, 35–41 (2018). https://doi.org/10.1007/s12565-016-0363-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12565-016-0363-9